In order to obtain this action we must pay 0,66$ right now, In this post we are going to talk about the listed company Acorda Therapeutics Inc, its leaders are Andrew R. Blight (Chief Scientific Officer Emeritus), Burkhard Blank (Chief Medical Officer, Head-R&D), Lauren M. Sabella (Chief Operating Officer), Ronald Cohen (President, Chief Executive Officer & Director), they lead it to work in Biotechnology: Biological Products (No Diagnostic Substances) especially in the North America region.
Today this action begins with yesterday's closing price, desconocido$.
With an intraday difference of 0,73$ moving between 0,61$ and 0,85$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The opening price that appears as last recorded is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
